sb 203580 has been researched along with Colitis, Granulomatous in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amagase, K; Andoh, A; Fujiyama, Y; Imaeda, H; Kobori, A; Sugihara, T; Takeuchi, K; Tsujikawa, T | 1 |
| Hollenbach, E; Malfertheiner, P; Naumann, M; Neumann, M; Roessner, A; Vieth, M | 1 |
| Nikolaus, S; Rosenstiel, P; Schreiber, S; Seegert, D; Waetzig, GH | 1 |
3 other study(ies) available for sb 203580 and Colitis, Granulomatous
| Article | Year |
|---|---|
The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease.
Topics: Adenoviridae; Colitis, Ulcerative; Colon; Complement C3; Crohn Disease; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Flavonoids; Gene Expression Regulation; Humans; I-kappa B Proteins; Imidazoles; Interleukin-17; Intestinal Mucosa; Male; Mitogen-Activated Protein Kinase 1; Mutation; NF-KappaB Inhibitor alpha; p38 Mitogen-Activated Protein Kinases; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transduction, Genetic | 2010 |
Inhibition of RICK/nuclear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn disease.
Topics: Animals; Crohn Disease; Cytokines; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Enzyme Inhibitors; Female; Imidazoles; Immunoblotting; Inflammation; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Models, Biological; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Protein Kinases; Pyridines; Receptor-Interacting Protein Serine-Threonine Kinase 2; Receptor-Interacting Protein Serine-Threonine Kinases; Subcellular Fractions; Trinitrobenzenesulfonic Acid; Up-Regulation | 2005 |
p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease.
Topics: Adult; Aged; Antibodies, Monoclonal; Cells, Cultured; Colitis, Ulcerative; Crohn Disease; Enzyme Activation; Enzyme Inhibitors; Female; Humans; Imidazoles; Infliximab; Intestinal Mucosa; Jurkat Cells; Male; Middle Aged; Mitogen-Activated Protein Kinase 14; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Signal Transduction; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |